Doyle Anthony purchased ~$220K in BioCryst Pharmaceuticals, Inc. stock
BioCryst Pharmaceuticals, Inc. (BCRX) · Chief Financial Officer · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
-2.0%vs SPY +7.0%
Trade Details · Public SEC Filing
Insider
Doyle Anthony
Role
Chief Financial Officer
Transaction
Open-Market Purchase
Approx. Value
~$220K
Trade Date
Aug 11, 2020
Company
BioCryst Pharmaceuticals, Inc.
Ticker
BCRXSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$220K purchase
A meaningful investment of personal capital. The average insider purchase is around $150K, putting this in the typical range for serious positions.
Chief Financial Officer
CFOs have direct access to financials before they become public. Their trades are among the most closely watched by institutional investors.
-2.0% in 90 days (S&P 500: +7.0%)
This trade underperformed the S&P 500 by 9.0 percentage points. Not every insider trade wins. We track all of them so you can focus on the insiders with the best records.
How good is Doyle Anthony at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
On August 11, 2020, Doyle Anthony — Chief Financial Officer of BioCryst Pharmaceuticals, Inc. — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$220K in BioCryst Pharmaceuticals, Inc. (BCRX) stock.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, BCRX returned -2.0% versus +7.0% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Doyle Anthony trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More BCRX Insider Activity
Browse all insider buys →How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free